Aberrant TNF signaling in pancreatic lymph nodes of patients with Type 1 Diabetes
M. Abedi, P. Rai, Y. Zhou, C. Liu, I. Johnson, A. Chandra, M. Fasolino, S. Rostami, K. H. Kaestner, A. Naji, R. B. Faryabi, G. Vahedi
This study identifies heightened TNF pathway activity and chromatin remodeling in pancreatic lymph node CD4+ T cells from T1D patients, supporting the use of TNF inhibitors in clinical trials.
bioRxiv · May 31, 2024 · PreprintImmunology